Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg.
about
Chimeric hepatitis B virus core particles with parts or copies of the hepatitis C virus core proteinReactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface proteinGenomic screening for blood-borne viruses in transfusion settings.Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in JapanSeroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia.HBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients.High Prevalence of Hepatitis B Virus Infection in Young Adults in Ternate, Eastern Indonesia.Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission.Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen.Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia.Acute hepatitis B infection associated with blood transfusion in England and Wales, 1991-7: review of database.Hepatitis B virus DNA in blood samples positive for antibodies to core antigen and negative for surface antigen.Circular double-stranded forms of TT virus DNA in the liver.Universal infant immunization and occult hepatitis B virus infection in children and adolescents: a population-based study.Infection with GB virus C in leprous patients in Japan.Infection with GB virus C and hepatitis C virus in hemodialysis patients and blood donors in Beijing.Infection with GB virus C and hepatitis C virus in drug addicts, patients on maintenance hemodialysis, or with chronic liver disease in Nepal.Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma.The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis.Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan.Infection with an unenveloped DNA virus (TTV) associated with posttransfusion non-A to G hepatitis in hepatitis patients and healthy blood donors in Thailand.Infection by an unenveloped DNA virus associated with non-A to -G hepatitis in Japanese blood donors with or without elevated ALT levels.Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.Clinical and molecular virological differences between fulminant hepatic failures following acute and chronic infection with hepatitis B virus.Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-tra
P2860
Q27486069-EBCC1108-D128-4DA1-9AE8-96C3F9ADF4B2Q30434625-3B7AA4BA-908D-4723-8E19-73F61F2D492EQ33743076-17A48553-9376-4F27-BEB5-334074336391Q33890340-BF06132A-BA7F-4EF8-91A1-EDD46B84771FQ35095916-2CF6AD15-9D0A-4832-B8DD-636BE407C586Q35156568-4D254E85-E6CC-4F06-BB8E-D7B849DB3525Q35356183-38D18D74-9A06-4983-A1C7-C28680AE8369Q35529204-63CCE984-B716-45B2-8D88-327EE81967DEQ35706571-D5BDA0FE-5460-4795-9AB1-A5EA965F12FAQ35782725-CCD09F86-B208-4588-8D4E-9CF6441E28B6Q36131759-29EA6932-8790-4720-BC68-9E4992B76F8EQ36632713-39BE04EB-573A-4490-9BB5-5B52B10F213EQ36637972-C675772A-B5D5-47D7-9F6E-1F47102FD6A2Q37015217-C01E6059-CD93-4C3B-8022-6ADF58B898EDQ37401121-DCE11009-ABE2-48C8-92FF-D5B4B590A934Q39506614-5655EBE3-B6E6-4155-8B67-AB66206EF533Q39585087-EAC17D67-2B6D-4003-8B6F-9D22232A8138Q41602121-FE47364F-2930-4CE2-B258-DAB3B6E39B0AQ42980875-84F92CBF-6564-433B-8931-F3735496363DQ42982611-BF081AFF-3A08-44AD-96E3-EF5E50459DABQ42985037-A8A12D3C-6A38-4A37-AC9B-978F29C25511Q42994894-9421273A-8354-41E8-9266-4CDF8A33D1F1Q43035321-C880B262-2B42-41E1-BEE8-032306770CC2Q43923526-05B106B5-A285-447A-9179-2084AE65605CQ44583128-066D7DB7-EA2C-4E85-8785-FA59F78C3D33Q44712719-A4AAE401-7341-4D2B-A90A-0E48AC8E8ACCQ45749343-C5AD74B9-A3A9-4967-9827-86070DCC8B12Q45754304-894E0568-3178-49BC-AC18-D6837C81EF2CQ45756207-B300A439-A3CC-47BF-BF96-60DEE3E306FAQ50522754-47D9B97D-2912-4965-AC74-516389C3715F
P2860
Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg.
@en
Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg.
@nl
type
label
Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg.
@en
Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg.
@nl
prefLabel
Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg.
@en
Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg.
@nl
P2093
P2860
P1433
P1476
Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg.
@en
P2093
Ishijima A
Miyakawa Y
P2860
P304
P356
10.1111/J.1423-0410.1992.TB02495.X
P577
1992-01-01T00:00:00Z